Rinvoq sustained-release tablets and Vemlidy tablets are sold a lot, so drug prices are cut…From June 1st |
2023-05-21 21:21:58 The drug price of AbbVie Korea’s Rinvoq sustained-release tablet (Eupadacitinib), used for the treatment of rheumatoid arthritis, and Gilead Sciences’ Vemlidi tablet (Temofovir